摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1S)-1-[(8S,9S,13S,14S,17S)-3-methoxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]ethanol | 4772-12-7

中文名称
——
中文别名
——
英文名称
(1S)-1-[(8S,9S,13S,14S,17S)-3-methoxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]ethanol
英文别名
——
(1S)-1-[(8S,9S,13S,14S,17S)-3-methoxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]ethanol化学式
CAS
4772-12-7
化学式
C21H30O2
mdl
——
分子量
314.468
InChiKey
SAMUNNKWOPDXFA-DATOPTFQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.2
  • 重原子数:
    23
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.71
  • 拓扑面积:
    29.5
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Helix 12 directed pharmaceutical products
    申请人:Labrie Fernand
    公开号:US20050250749A1
    公开(公告)日:2005-11-10
    Compounds having the structure or their salts: are used to treat or reduce le likelihood of acquiring androgen-dependent diseases, such as prostate cancer, benign prostatic hyperplasia, polycystic ovarian syndrome, acne, hirsutism, seborrhea, androgenic alopecia and male baldness. They can be formulated together with pharmaceutically acceptable diluent or carrier or otherwise made into any pharmaceutical dosage form. Some of these compounds having tissue-specific antiandrogenic activity and tissue-specific androgenic activity can be used to treat or reduce the risk of developing diseases related to loss of androgenic stimulation. Combinations with other active pharmaceutical agents are also disclosed.
    具有以下结构或其盐的化合物:用于治疗或减少获得雄激素依赖性疾病的可能性,例如前列腺癌、良性前列腺增生、多囊卵巢综合症、痤疮、多毛症、脂溢性皮炎、雄激素性脱发和男性秃发。它们可以与药学上可接受的稀释剂或载体一起制成任何药物剂型。其中一些具有组织特异性抗雄激素活性和组织特异性雄激素活性的化合物可用于治疗或减少与雄激素刺激丧失相关的疾病的风险。还公开了与其他活性药物的组合。
  • 19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors
    申请人:MERRELL DOW PHARMACEUTICALS INC.
    公开号:EP0348910A2
    公开(公告)日:1990-01-03
    19-Substituted progesterone derivatives and related compounds which are active as 19-hydroxylase inhibitors and useful as antihypertensive agents are described herein. The compounds are prepared using appropriate synthetic pathways which will vary according to the nature of the specific 19-substituted progesterone or related compound desired.
    本文介绍了具有 19-羟化酶抑制剂活性并可用作降压药的 19-取代孕酮衍生物及相关化合物。这些化合物是通过适当的合成途径制备的,合成途径因所需的特定 19-取代孕酮或相关化合物的性质而异。
  • US4910191A
    申请人:——
    公开号:US4910191A
    公开(公告)日:1990-03-20
  • US9090651B2
    申请人:——
    公开号:US9090651B2
    公开(公告)日:2015-07-28
  • Synthesis of novel estrone analogs by incorporation of thiophenols via conjugate addition to an enone side chain
    作者:Lucas C. Kopel、Mahmoud S. Ahmed、Fathi T. Halaweish
    DOI:10.1016/j.steroids.2013.07.005
    日期:2013.11
    Functionalized estrogen analogs have received interest due their unique and differning activity compared th their parent compounds. The synthesis of a tionalized at the C17 position possessing both alkyl and described, along with their thiophenol conjugate addition to their unique and differing biological activnew class of 3-methoxyestrone analogs funcaryl substituted ot,alpha,beta-unsaturated ketones is products. (C) 2013 Published by Elsevier Inc.
查看更多